
CMNDF
US listing · $10.4M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 31, 2021 | Time not confirmed | 0.00 | -0.03 | — |
| Apr 30, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Jan 31, 2021 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2018 | Time not confirmed | 0.00 | -0.01 | — |
| Jul 31, 2018 | Time not confirmed | 0.00 | -0.00 | — |
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to…
| Apr 30, 2018 |
| Time not confirmed |
| 0.00 |
| -0.00 |
| — |
| Jan 31, 2018 | Time not confirmed | 0.00 | -0.02 | — |